Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8135070 | 8404623 | I | 8135070-0 | 20120210 | 20120214 | PER | US-PFIZER INC-2012036987 | PFIZERINC | YR | Y | 20120214 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8135070 | 1018855205 | C | PRIMIDONE | 2 | 250 MG, 1 1/2 IN AM, 1 1/2 IN PM | ||||||
| 8135070 | 1018855210 | C | WARFARIN | 2 | 10 MG, 1 IN PM | ||||||
| 8135070 | 1018855211 | C | OS-CAL D | 2 | 500 MG, 2X/DAY (W/ MEALS) | ||||||
| 8135070 | 1018855206 | C | PRIMIDONE | 2 | 50 MG, 2 IN AM | ||||||
| 8135070 | 1018855209 | C | BETAPACE | 1 | 80 MG, 2X/DAY | ||||||
| 8135070 | 1018855212 | C | PRAVASTATIN SODIUM | 2 | 80 MG, 1X/DAY | ||||||
| 8135070 | 1018855214 | C | NEXIUM | 1 | 40 MG, 1 IN PM | ||||||
| 8135070 | 1018855204 | PS | CELEBREX | 1 | ORAL | 200 MG, 1X/DAY | 020998 | ||||
| 8135070 | 1018855207 | C | METHOCARBAMOL | 2 | 750 MG, AS NEEDED (EVERY 8 HOURS AS NEEDED) | ||||||
| 8135070 | 1018855213 | C | TERBINAFINE | 2 | 250 MG, 1X/DAY | ||||||
| 8135070 | 1018855208 | C | GABAPENTIN | 2 | 300 MG, 3X/DAY |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8135070 | 1018855212 | BLOOD CHOLESTEROL |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 8135070 | BLOOD CHOLESTEROL INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8135070 | 1018855213 | 91 | DAY |